METTL3 and acute myeloid leukemia: 4‐[2‐[5‐chloro‐1‐(diphenylmethyl)‐2‐methyl‐1H‐indol‐3‐yl]‐ethoxy]benzoic acid (CDIBA) and eltrombopag are METTL3 allosteric inhibitors which inhibit the proliferation of AML cells.181, 182